Augmentation of prefrontal cortical monoaminergic activity inhibits dopamine release in the caudate nucleus: Anin vivo neurochemical assessment in the rhesus monkey
暂无分享,去创建一个
[1] Koh Hh,et al. Effects of ketamine on brain monoamine levels in rats. , 1978 .
[2] Ariel Y. Deutch,et al. Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress , 1990, Brain Research.
[3] W. Nauta,et al. An intricately patterned prefronto‐caudate projection in the rhesus monkey , 1977, The Journal of comparative neurology.
[4] G. Aghajanian,et al. Effects of Amphetamine on Single Cell Activity in a Catecholamine Nucleus, the Locus Coeruleus , 1971, Nature.
[5] R. Roth,et al. Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems , 1992, Neuroscience.
[6] P. Goldman-Rakic,et al. In vivo assessment of basal and drug‐induced dopamine release in cortical and subcortical regions of the anesthetized primate , 1993, Synapse.
[7] N. Koshikawa,et al. Ketamine anaesthesia has no effect on striatal dopamine metabolism in rats , 1988, Brain Research.
[8] C. Carter,et al. Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats , 1980, Nature.
[9] M. Le Moal,et al. Presynaptic control of dopamine metabolism in the nucleus accumbens. Lack of effect of buspirone as demonstrated using in vivo voltammetry. , 1987, Life sciences.
[10] J. Glowinski,et al. AN ADAPTATION OF THE PUSH‐PULL CANNULA METHOD TO STUDY THE IN VIVO RELEASE OF [3H]DOPAMINE SYNTHESIZED FROM [3H]TYROSINE IN THE CAT CAUDATE NUCLEUS: EFFECTS OF VARIOUS PHYSICAL AND PHARMACOLOGICAL TREATMENTS , 1977, Journal of neurochemistry.
[11] P. Goldman-Rakic,et al. Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[12] A. D. Smith,et al. Identification of synaptic terminals of thalamic or cortical origin in contact with distinct medium‐size spiny neurons in the rat neostriatum , 1988, The Journal of comparative neurology.
[13] J. Fallon,et al. Catecholamine innervation of the basal forebrain IV. Topography of the dopamine projection to the basal forebrain and neostriatum , 1978, The Journal of comparative neurology.
[14] P F Morrison,et al. Effects of Different Semipermeable Membranes on In Vitro and In Vivo Performance of Microdialysis Probes , 1990, Journal of neurochemistry.
[15] R. Hassler,et al. Effect of frontal cortex ablation on striatal glutamic acid level in rat , 1977, Brain Research.
[16] P. Goldman-Rakic,et al. The anatomy of dopamine in monkey and human prefrontal cortex. , 1992, Journal of neural transmission. Supplementum.
[17] A. Young,et al. Excitatory Amino Acid Neurotransmitters in the Corticostriate Pathway: Studies Using Intracerebral Microdialysis In Vivo , 1986, Journal of neurochemistry.
[18] R. Saunders,et al. An improved methodology for routine in vivo microdialysis in non-human primates , 1994, Journal of Neuroscience Methods.
[19] G. Aghajanian,et al. Reserpine suppression of dorsal raphe neuronal firing: mediation by adrenergic system. , 1978, European journal of pharmacology.
[20] P. Goldman-Rakic,et al. Heterogeneous targets of dopamine synapses in monkey prefrontal cortex demonstrated by serial section electron microscopy: a laminar analysis using the silver-enhanced diaminobenzidine sulfide (SEDS) immunolabeling technique. , 1993, Cerebral cortex.
[21] G. Cohen,et al. Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices. , 1975, Biochemical pharmacology.
[22] A. Deutch. The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. , 1992, Journal of neural transmission. Supplementum.
[23] T. Goldberg,et al. Learning and memory in monozygotic twins discordant for schizophrenia , 1993, Psychological Medicine.
[24] B. Westerink,et al. Scope and limitations of in vivo brain dialysis: a comparison of its application to various neurotransmitter systems. , 1987, Life sciences.
[25] D. Rosene,et al. A cryoprotection method that facilitates cutting frozen sections of whole monkey brains for histological and histochemical processing without freezing artifact. , 1986, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[26] T. Robinson,et al. Microdialysis in the neurosciences , 1991 .
[27] J. Glowinski,et al. The mesocortico-prefrontal dopaminergic neurons , 1984, Trends in Neurosciences.
[28] U. Ungerstedt,et al. An in vivo microdialysis characterization of extracellular dopamine and GABA in dorsolateral striatum of awake freely moving and halothane anaesthetised rats , 1990, Journal of Neuroscience Methods.
[29] H. Herdon,et al. Differences between the release of radiolabelled and endogenous dopamine from superfused rat brain slices: Effects of depolarizing stimuli, amphetamine and synthesis inhibition , 1985, Brain Research.
[30] T. Thompson. American Psychiatric Press Review of Psychiatry, vol. 12 , 1994 .
[31] S. Sesack,et al. In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other , 1990, Brain Research.
[32] A. Mcgeorge,et al. The organization of the projection from the cerebral cortex to the striatum in the rat , 1989, Neuroscience.
[33] D. Weinberger. Implications of normal brain development for the pathogenesis of schizophrenia. , 1987, Archives of general psychiatry.
[34] Hugh J. Spencer. Antagonism of cortical excitation of striatal neurons by glutamic acid diethyl ester: Evidence for glutamic acid as an excitatory transmitter in the rat striatum , 1976, Brain Research.
[35] J. Scheel-Krüger,et al. Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain. , 1971, European journal of pharmacology.
[36] H. Fibiger,et al. Electrical Stimulation of the Medial Prefrontal Cortex Increases Dopamine Release in the Striatum , 1993, Neuropsychopharmacology.
[37] K. E. Moore,et al. D-amphetamine-induced release of "newly synthesized" and "stored" dopamine from the caudate nucleus in vivo. , 1975, The Journal of pharmacology and experimental therapeutics.
[38] C. A. Marsden,et al. Measurement of neurotransmitter release in vivo , 1984 .
[39] U. Ungerstedt,et al. An In Vivo Study of Dopamine Release and Metabolism in Rat Brain Regions Using Intracerebral Dialysis , 1986, Journal of neurochemistry.
[40] R. Roth,et al. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: An anterograde tract‐tracing study with Phaseolus vulgaris leucoagglutinin , 1989, The Journal of comparative neurology.
[41] J. Desce,et al. l-Glutamate-evoked release of dopamine from synaptosomes of the rat striatum: Involvement of AMPA and N-methyl-d-aspartate receptors , 1992, Neuroscience.
[42] A. Grace. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia , 1991, Neuroscience.
[43] R. M. Beckstead,et al. Striatal preprotachykinin and preproenkephalin mRNA levels and the levels of nigral substance P and pallidal Met5-enkephalin depend on corticostriatal axons that use the excitatory amino acid neurotransmitters aspartate and glutamate: quantitative radioimmunocytochemical and in situ hybridization ev , 1990, Brain research. Molecular brain research.
[44] R. E. Study,et al. Isoflurane Inhibits Multiple Voltage‐gated Calcium Currents in Hippocampal Pyramidal Neurons , 1994, Anesthesiology.
[45] S. D. Glick,et al. Similar effects ofd-amphetamine and cocaine on extracellular dopamine levels in medial prefrontal cortex of rats , 1990, Brain Research.
[46] D. Weinberger,et al. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. , 1988, Archives of general psychiatry.
[47] M. Reilly,et al. Intraneuronal dopaminergic action of cocaine and some of its metabolites and analogs , 1983, Neuropharmacology.
[48] E. Rubinstein,et al. Comparison of ketamine, physical restraint, halothane and pentobarbital: Lack of influence on serotonergic measures in monkeys and rats , 1987, Neuropharmacology.
[49] H. Benveniste,et al. Determination of Brain Interstitial Concentrations by Microdialysis , 1989, Journal of neurochemistry.
[50] B. Moghaddam,et al. Differential effect of cocaine on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens: Comparison to amphetamine , 1989, Synapse.
[51] J. Lehmann,et al. The striatal cholinergic interneuron: Synaptic target of dopaminergic terminals? , 1983, Neuroscience.
[52] U. Ungerstedt,et al. Anaesthesia effects on in vivo acetylcholine transmission; comparisons of radioenzymatic and HPLC assays. , 1990, European journal of pharmacology.
[53] A C Roberts,et al. 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: possible interactions with subcortical dopamine , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[54] Douglas W. Jones,et al. The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[55] P. Goldman-Rakic,et al. Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[56] P. Goldman-Rakic,et al. Topography of Corticostriatal Projections in Nonhuman Primates and Implications for Functional Parcellation of the Neostriatum , 1986 .
[57] B. Westerink,et al. Chronic Use of Intracerebral Dialysis for the In Vivo Measurement of 3,4‐Dihydroxyphenylethylamine and Its Metabolite 3,4‐Dihydroxyphenylacetic Acid , 1986, Journal of Neurochemistry.
[58] J. Hsiao,et al. In vivo changes of catecholamines in hemiparkinsonian monkeys measured by microdialysis , 1990, Experimental Neurology.
[59] L. Saarnivaara,et al. Effect of Ketamine Anaesthesia on the Content of Monoamines and their Metabolites in the Rat Brain , 1976, Acta anaesthesiologica Scandinavica.
[60] L. Cubeddu,et al. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores. , 1986, The Journal of pharmacology and experimental therapeutics.
[61] P. Herrling. Pharmacology of the corticocaudate excitatory postsynaptic potential in the cat: Evidence for its mediation by quisqualateor kainate-receptors , 1985, Neuroscience.
[62] T. Svensson,et al. Local cooling of pre-frontal cortex induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo. , 1989, Acta physiologica Scandinavica.
[63] S. Iversen,et al. Effect of injections of 6-OHDA into either nucleus accumbens septi or frontal cortex on spontaneous and drug-induced activity , 1983, Neuropharmacology.
[64] D. Weinberger,et al. Dopamine and schizophrenia—a cortically corrective perspective , 1992 .
[65] S. L. Liles. Single-unit responses of caudate neurons to stimulation of frontal cortex, substantia nigra and entopeduncular nucleus in cats. , 1974, Journal of neurophysiology.
[66] U. Ungerstedt,et al. In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. , 1988, European journal of pharmacology.
[67] Tadaharu Tsumoto,et al. Excitatory amino acid transmitters and their receptors in neural circuits of the cerebral neocortex , 1990, Neuroscience Research.
[68] K. Davis,et al. Dopamine in schizophrenia: a review and reconceptualization. , 1991, The American journal of psychiatry.
[69] D. Weinberger,et al. Microinjection of apomorphine into the prefrontal cortex of the rat reduces dopamine metabolite concentrations in microdialysate from the caudate nucleus , 1991, Biological Psychiatry.
[70] G. Gessa,et al. (—)-Sulpiride activates the firing rate and tyrosine hydroxylase activity of dopaminergic neurons in unanesthetized rats , 1983, Brain Research.
[71] D. Weinberger,et al. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. IV. Further evidence for regional and behavioral specificity. , 1988, Archives of general psychiatry.
[72] M. Le Moal,et al. Opposite influences of dopaminergic pathways to the prefrontal cortex or the septum on the dopaminergic transmission in the nucleus accumbens. An in vivo voltammetric study , 1989, Neuroscience.
[73] F. Gonon,et al. Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo , 1993, Neuroscience Letters.
[74] Philip Seeman,et al. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine , 1991, Nature.
[75] R. Roth,et al. Pharmacology of mesocortical dopamine neurons. , 1983, Pharmacological reviews.